New Drug Application Filed for Antibody-Drug Conjugate

Trastuzumab Emtansine for the Treatment of HER2-Positive Metastatic or Recurrent Breast Cancer
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news